Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam add-on therapy for drug-resistant epilepsy in adults
ChiCTR2400084153Phase 4Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-sen University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clobazam in epilepsy (2 arms), sponsored by The Seventh Affiliated Hospital, Sun Yat-sen University. Primary endpoints: Proportion of patients with at least 50% reduction in seizure frequency at week 24 and Median reduction in seizure frequency. Planned start May 2024; status: not yet recruiting.
02
Drugs
clobazam
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2400084153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084153.